In summary, the mechanistic and therapeutic significance of METTL14 positions it as a pivotal link between epitranscriptomic regulation and tumor immune responses, setting the stage for a deeper discussion of its role in immunotherapy efficacy. The gene discussed is METTL14; the disease is neoplasm.